date,title,source
Oct-22-18,"Arcus Biosciences Appoints Kristen M. Hege, M.D., to its Board of Directors",Business Wire
Nov-01-18,Arcus Biosciences Announces Participation at Three Investor Conferences in November,Business Wire
Nov-08-18,Arcus Biosciences Announces Third Quarter 2018 Financial Results and Recent Corporate Updates,Business Wire
Nov-09-18,"Arcus Biosciences Presents Initial Data from the Phase 1 Dose-Escalation Study of AB122, its anti-PD-1 antibody, at the SITC 2018 Annual Meeting",Business Wire
Nov-16-18,"Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Jan-02-19,Here are the winners and losers from Bay Area's IPO class of 2018,American City Business Journals
Jan-04-19,"Why Arcus Biosciences, Eldorado Gold, and Esperion Therapeutics Slumped Today",Motley Fool
Jan-04-19,Arcus Biosciences Announces Transition of Chief Financial and Operating Officer,Business Wire
Feb-13-19,Arcus Biosciences Announces Participation at Upcoming Investor Conference,Business Wire
Feb-28-19,Arcus Biosciences Announces Upcoming Presentations at the 2019 American Association for Cancer Research Annual Meeting,Business Wire
Mar-05-19,Arcus Biosciences Announces Fourth Quarter and Full Year 2018 Financial Results and Recent Corporate Updates,Business Wire
Mar-15-19,Infinity Inks Deal With Roche for Phase II Study of IPI-549,Zacks
Mar-25-19,Arcus Biosciences Appoints Rekha Hemrajani as Chief Operating and Financial Officer,Business Wire
Apr-11-19,"What Kind Of Shareholders Own Arcus Biosciences, Inc. (NYSE:RCUS)?",Simply Wall St.
Apr-11-19,"Arcus Biosciences, Inc. (RCUS) Shares March Higher, Can It Continue?",Zacks
Apr-25-19,"Alexion (ALXN) Q1 Earnings Beat Estimates, Guidance Raised",Zacks
Apr-29-19,Arcus (RCUS) to Report Q1 Earnings: What's in the Cards?,Zacks
May-02-19,Arcus Biosciences Announces First Quarter 2019 Financial Results and Recent Corporate Updates,Business Wire
May-02-19,"Arcus Biosciences Appoints William Grossman, M.D., Ph.D., Chief Medical Officer",Business Wire
May-02-19,Arcus Biosciences and Strata Oncology Announce Clinical Development Collaboration for Anti-PD-1 Antibody AB122,Business Wire
May-08-19,Infinity (INFI) Earnings and Sales Miss Estimates in Q1,Zacks
May-08-19,Trade Anxieties Return with a Vengeance,Zacks
May-21-19,Arcus Biosciences to Present at the Jefferies 2019 Global Healthcare Conference,Business Wire
May-29-19,Arcus Biosciences to Present Preliminary Data from the Ongoing Phase 1 Dose-Escalation Trials of AB928 in Combination with Chemotherapy or AB122 at the 2019 ASCO Annual Meeting,Business Wire
Jun-05-19,"Arcus Biosciences Inc (RCUS) CEO Terry J Rosen Bought $328,581 of Shares",GuruFocus.com
Jun-07-19,"Arcus Biosciences Inc (RCUS) CEO Terry J Rosen Bought $172,382 of Shares",GuruFocus.com
